Recruiting urologists

Surveillance, surgery, or radiation — the decisions urology patients lose sleep over deserve a second set of eyes

Paid, signed second-opinion reviews through SecondOpinionMedical.AI — asynchronous, record-based, on your schedule. Every application is verified against the NPPES NPI registry and screened against the OIG LEIE exclusions list before approval.

Why this specialty

Why Urology fits the network

Urology owns one of the highest-stakes preference-sensitive decisions in medicine: what to do about localized prostate cancer. Active surveillance, prostatectomy, and radiation can all be defensible for the same Gleason score, which is precisely why patients seek an independent urologist before committing — and why a written second opinion from an assembled record is so valuable. The same pattern repeats upstream (does this PSA trajectory justify a biopsy, and was MRI used appropriately first?) and across the specialty, from small renal masses to recurrent stones.

SecondOpinionMedical.AI retrieves the full record — PSA history with dates, MRI and biopsy pathology reports, imaging for masses and stones, urodynamics, operative notes — and assembles it through multi-engine AI synthesis into a single package with the timeline reconciled. As the urologist medical second opinion reviewer, you weigh the options as you would for your own patient and render a signed written opinion. Every reviewer is NPI-verified through NPPES and screened against the OIG exclusions list before reviewing a case.

For urologists whose weeks revolve around the OR and cystoscopy schedule, remote urology case review is surgical judgment without the surgery: asynchronous, per-case, and shaped to fit around block time — urology telehealth side income that draws on the decision-making, not the operating.

Physicians arrive here searching for different things — “urology second opinion”, “prostate cancer second opinion”, “remote urology case review”, “urologic surgery review” — and this page covers all of them.

On the platform

Representative case types

Elevated PSA — biopsy now or not?

PSA kinetics, prior negative biopsies, and MRI PI-RADS findings weighed together: whether fusion biopsy is indicated now, or continued monitoring with risk-calculator context is the sounder call.

Localized prostate cancer treatment choice

Gleason grade group, volume of disease, and patient factors against the three-way choice of active surveillance, prostatectomy, and radiation — including whether the surveillance protocol proposed is rigorous enough to be safe.

Small renal mass management

Incidental renal masses at the surveillance–biopsy–partial-nephrectomy margin: an independent read on growth kinetics, biopsy utility, and nephron-sparing options.

Recurrent stone disease workup

Multiple stone events without a completed metabolic evaluation — auditing the 24-hour urine data, prevention regimen, and whether procedural choices match stone burden and anatomy.

BPH procedure selection

Medication-refractory lower urinary tract symptoms: matching prostate size, anatomy, and patient priorities to the expanding menu of resection, enucleation, and minimally invasive options.

Hematuria evaluation completeness

Microscopic or gross hematuria where the workup stopped short — confirming whether imaging and cystoscopy decisions matched guideline risk stratification.

Practice fit

How it fits your week — and how it pays

Workflow fit

Urology second opinions run on documents — PSA curves, pathology reports, imaging, urodynamics — delivered as one assembled package, so the work slots into the gaps a surgical schedule actually produces: a canceled case, an early OR finish, an evening. Nothing is live, nothing is on call, and there is no perioperative responsibility; your deliverable is a signed written opinion the patient brings back to their treating urologist. Reviewers with oncology or reconstructive fellowship training are matched to those cases specifically.

Compensation, plainly

Each case posts a per-case honorarium, fixed and visible before you accept. Complex multi-modality treatment-decision reviews are weighted more heavily than single-question reviews, and there are no quotas — surgeons routinely scale participation up and down around block schedules.

Board certifications we recognize for Urology:

American Board of Urology (ABU)ABU — Urologic Oncology (fellowship-trained)ABU — Female Pelvic Medicine and Reconstructive Surgery

Questions

Urology FAQs

For urology, yes — because the decisions patients most want re-examined are pre-surgical: whether to biopsy, whether to treat, which modality to choose. Those are judgment calls made from PSA history, imaging, and pathology, all of which arrive in the assembled package. You are not operating remotely; you are deciding whether you would operate, and saying why in writing.

Packages include the formal pathology reports, and your opinion is rendered on the documented record. When grade assignment is pivotal and the record suggests uncertainty, your opinion can recommend formal pathology re-review as part of its guidance — flagging that need is a legitimate and common second-opinion conclusion.

Entirely at your discretion. Cases queue and you accept what a given week allows; there are no minimums, no shifts, and no penalty for quiet stretches around heavy block weeks. Each case carries a stated review window you can see before accepting.

No visits, no coverage, no patient management. This is patient-initiated, records-based consultative review: the platform retrieves and synthesizes the chart, you contribute a signed independent opinion, and the treating urologist retains care of the patient. It is expert consultation, not clinical staffing.

A per-case honorarium set before you accept each case — you always see the fee and scope first. Fees scale with the depth of review a case demands rather than with time logged, and declining cases never affects what you are offered next.

Across the network

Also recruiting

Join the Network

Apply once — verification is the front door

Tell us about your practice on the product page. Every application is verified against the NPPES NPI registry and screened against the OIG LEIE exclusions list before approval. Patients only ever see verified, board-certified physicians.